Healthcare Research Blog: November 2018

Friday, November 30, 2018

Jet Injector Device Market: Size, Share, Emerging Trends, Analysis and Forecasts to 2025

Jet injector device is a medical device that uses a needle-free injection system. The injector delivers drugs, vaccines, compounds, anesthetics, steroids, or insulin in a very fine stream of fluid by high-pressure precision. The high pressure is produced either by using nitrogen-filled or carbon-dioxide-filled cartridge or a spring. The medication is forced through a tiny opening in the device, which allows the drug to penetrate the skin and is administered into the underlying tissue either intramuscularly, subcutaneously, or intradermal.

Report Overview @ https://www.transparencymarketresearch.com/jet-injector-device-market.html

The jet injector device provides (with minimal training) reproducible, reliable, and accurate delivery of medication, eliminates the need for “sharps” disposal, reduces risks such as cross-contamination and needle stick injuries, enhances compliance, and is less painful for the patient. These attributes are expected to drive the global jet injector device market. Increased inclination toward minimal invasive methods can further boost the demand for jet injectors. Improved patient convenience due to ease in professional and self-medication uses can drive the growth of the market during the forecast period. According to the International Diabetes Federation, the rate of diagnosis of diabetes has increased from 30 million people to 246 million people in India, China, and the U.S., over the last decades. Increasing incidence of diabetes drives the jet injector devices market. However, some formulations of vaccines and medications produce a stinging or burning sensation, whether it is administered using a jet injector or a needle.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30641

The global jet injector device market can be segmented based onproduct type, methods of injection, end-user, medication type, and region. In terms of product type, the market can be classified into powder jet injections, liquid jet injections, and depot or projectile jet injections. Based on the methods of injection, the market can be classified into gas powdered jet injector, spring load jet injector, and battery powdered jet injector. In terms of end-user, the market can be categorized into podiatric clinics, dental clinics, veterinary clinics, ambulatory surgical centers, and hospitals. In terms of the medication type, the global jet injector device market can be divided into vaccines, drugs, aesthetics, hormones, genes, and others.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=30641

Geographically, the global jet injector device market can be classified into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a dominant market share in the year 2016, owing to technological advancements in research & development, high awareness, and early adoption of jet injector devices. Europe held the second largest market share in 2016 due to government initiatives to promote good health in the region. Asia Pacific market is expected to expand during the forecast period. The growth can be accredited to increasing life expectancy in the region. According to World Health Organization (WHO), life expectancy continues to rise in the South East Asia region. Since 2000, life expectancy has increased at nearly 3.5 years per decade. The life expectancy in the region was 69.0 in 2015. The global jet injector device market in Africa is anticipated to grow during the forecast period owing to the increasing prevalence of diabetes. According to WHO, by 2030, the estimated number of diabetes cases will reach nearly 23.9 million in Africa. In surveys carried out by WHO, approximately 15% of adults between the ages of 25 and64 suffer from diabetes.

Key players of the global jet injector device market are PharmaJet, MK Global Co., Spirit Healthcare Ltd, Valeritas, Inc, Lundbeck Limited, Crossject needle-free injection systems, InjexUK, and Antares Pharma.

Popular Research Reports by TMR:

Orthopedic Devices Market: https://www.prnewswire.com/news-releases/orthopedic-devices-market-is-anticipated-to-reach-us-65-000-mn-by-2026-says-tmr-880357057.html

Hemoglobin A1c Testing Devices Market : https://globenewswire.com/news-release/2018/07/09/1534631/0/en/Global-Hemoglobin-A1c-Testing-Devices-Market-to-Exhibit-10-30-CAGR-Rising-Prevalence-of-Diabetes-Globally-to-Drive-Growth.html

Veterinary Catheters Market: Segmentation, Opportunities, Trends & Future Scope to 2025

Veterinary catheters are the tubes used to deliver medications, fluids, and gases to the body or to drain waste fluids such as urine from the body of the animals. Catheters are inserted into the blood vessels, ducts, or body cavities. The process of catheter insertion is called catheterization. Catheter insertion is a relatively safe procedure; however, trauma can be caused to urethra or the bladder occasionally. Use of soft tip catheters and lubricants can minimize the discomfort. The global catheters market is well established with large number of leading players.

Report Overview @ https://www.transparencymarketresearch.com/veterinary-catheters-market.html

A key trend followed by many leading players is development of high quality silicone catheters with minimal discomfort. Film coating of catheters by neutral polymers is a key development strategy. Kidney diseases are the major causes of morbidity in dogs and cats. The rising prevalence of chronic kidney diseases and cardiovascular diseases in animals, increasing number of companion animals, and advanced veterinary health care techniques are driving the global veterinary catheters market. However, poor diagnosis of diseases in developing countries, lack of awareness about animal health, risk of urinary leakage in the abdomen, and rising incidences of urinary tract infections due to catheter use are the factors restraining the global veterinary catheters market growth.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30494

The global veterinary catheters market can be segmented based on its application, physical nature, purpose of insertion, material of construction, and region. Based on application, the global veterinary catheters market can be segmented into urinary catheters, insemination catheters, neurovascular catheters, cardiovascular catheters, intravenous catheters, and specialty catheters. Based on application, the urinary catheters market is segmented into diagnostic catheters, dialysis catheters, and treatment catheters. Diagnostic catheters are used to collect the urine for analysis, for determination of specific gravity of urine, and for urine cytology analysis. Dialysis catheters are of two types-peritoneal catheters and hemodialysis catheters. Treatment catheters are used for urinary diversion in animals, for retrograde movement of obstructed uroliths (bladder stones), to treat detrusor atony of the bladder, and as a guide to urethral surgery. Based on product type, urinary catheters are classified as foley catheters, malecot catheters, mushroom-tip catheters, and low-profile tubes. Foley catheters contain an inflatable balloon at the tip which retains the catheter in place in the bladder. Mushroom-tip catheters are made with a rigid tip which is less prone to dislodging. Malecot catheter is an over-the-needle type catheter. It is inserted percutaneously in cats or dogs. However, care should be taken to prevent the leakage of urine in the abdomen. Based on the period of insertion, urinary catheters are further segmented into indwelling catheters and intermittent catheters. Indwelling catheters are placed in the bladder for days or weeks. Intermittent catheters are inserted at the time of urination and removed once the bladder is empty. Cardiovascular catheters are classified into angiography catheters, PTCA balloon catheters, pulmonary artery catheters, OCT catheters, pressure & hemodynamic monitoring catheters, electrophysiology catheters, and IVUS catheters. Cardiovascular catheters and urinary catheters have the highest market share due to rising incidences of cardiac diseases and urinary complications among pets. The intravenous catheters market is segmented into central venous catheters and peripheral venous catheters. Peripheral venous catheters are further classified as integrated catheters and short catheters. For small animals, peripheral venous catheters in the size ranging from 18 gauge to 24 gauge are used. The specialty catheters market is segmented into IUI catheters, oximetry catheters, thermodilution catheters, and wound/surgical drain catheters.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=30494

On the basis of physical nature, the global veterinary catheters market can be segmented into soft catheters and hard catheters. Soft catheters are thin & flexible, whereas hard catheters are hard and rigid. On the basis of material of construction, the global veterinary catheters market is segmented into polyethylene terephthalate (PET), vinyl, latex, rubber, silicone, nylon, polyurethane, and thermoplastic elastomer catheters. Among these, silicon catheters are preferred due to its inertness toward bodily fluids.

Based on region, the global veterinary catheters market can be segmented into North America, Latin America, Europe, Middle East & Africa, and Asia Pacific. North America is leading the market due to presence of highest number of companion animals, advanced veterinary care centers, and rising prevalence of kidney diseases. After North America, Europe is largest market for veterinary catheters. Asia Pacific is expected to grow as a potential market during the forecast period.

Key players operating in the global veterinary catheters market are, Kruuse Products, Vygon Vet, Biomerics Advanced Catheter, Jorgensen Laboratories, B. Braun Melsungen AG,Infiniti Medical, SAI Infusion Technologies, Vitality Medical, and Covidien Plc.

Popular Research Reports by TMR:

Esoteric Testing Market: Research Analysis by Basic Information, Manufacturing Base, Sales Area and Regions

Esoteric testing is the analysis of ‘rare’ molecules or substances. It is not performed in a routine clinical laboratory. These test are performed when there is requirement of additional information external routine lab testing, for proper diagnosis of disease, establish a prognosis or select and supervise a therapeutic treatment. Esoteric testing requires skilled personnel to perform the test and analyze the results due to usage of sophisticated chemicals and instruments. The tests are performed by specialized and independent clinical reference laboratories owing to high cost. It is not feasible for physician office laboratories and hospitals to perform these tests in-house. The test are regulated by regulatory stringent regulatory framework. These tests are not performed regularly.

Report Overview @ https://www.transparencymarketresearch.com/esoteric-testing-market.html

Based on test type, the global esoteric testing market has been segmented into genetics, endocrinology, immunology, molecular diagnostics, microbiology, oncology, serology, and toxicology. Molecular diagnostics is the fastest growing segment of the market, followed by the immunology and oncology segments, owing to increased prevalence of rare and genetic diseases and high demand for personalized medicine treatment. In terms of technology, the esoteric testing market has been segmented into chemiluminescence, ELISA, mass spectrometry, real time PCR, and flow cytometry. The chemiluminescence segment is expected to witness strong growth, followed by ELISA, because it is the most widely used technology in esoteric testing due to high efficiency and small sample required for testing. The real time PCR segment is expected to be driven by rise in prevalence of genetic disease and increase in demand for genetic testing. Growing use of information technology has allowed instant and efficient data transfer. These developments will provide more efficient results and improved patient care creates huge demand for esoteric testing market. Complex diseases difficult to diagnose and treat through conventional methods are diagnosed using esoteric testing. Rising prevalence of such complex and rare medical diseases is expected to contribute to the growth of the esoteric testing market. Additionally, high investments in proteomics, increasing demand for personalized medicine, and genomics boost the growth of the esoteric testing market. However, stringent government regulations and dearth of qualified and trained professionals are likely to restrain the esoteric testing market.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30377

In terms of region, the global esoteric testing market can be classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the esoteric testing market, followed by Europe, due to higher incidence and prevalence rate, growing awareness about early disease detection, and quick adoption of sophisticated instruments. Asia Pacific is an emerging market for esoteric testing due to increasing prevalence of disease, gradual development of medical infrastructure, rising awareness, and significant patient pool with unmet medical needs. However, high cost, lack of availability of trained personnel, and poor patient awareness are factors restraining the esoteric testing market in regions such as Middle East & Africa and Latin America.

Major players operating in the esoteric testing market include Laboratory Corporation of America Holdings, OPKO Health, Inc., ARUP Laboratories, Genomic Health, Inc., Quest Diagnostics, American Medical Laboratories, Gold Standard Diagnostics Corp, and ZeptoMetrix Corporation.

Popular Research Reports by TMR:

Orthopedic Devices Market: https://www.prnewswire.com/news-releases/orthopedic-devices-market-is-anticipated-to-reach-us-65-000-mn-by-2026-says-tmr-880357057.html

Hemoglobin A1c Testing Devices Market : https://globenewswire.com/news-
release/2018/07/09/1534631/0/en/Global-Hemoglobin-A1c-Testing-Devices-Market-to-Exhibit-10-30-CAGR-Rising-Prevalence-of-Diabetes-Globally-to-Drive-Growth.html

Vaginal Pessaries Market: Global Segments, Top Key Players, Size and Recent Trends by Forecast to 2025

Vaginal pessary is a medical device to be inserted in the vagina either to support pelvic organs such as uterus (womb), vagina, bladder, or rectum or to deliver medications. Pessaries are very useful as a non-surgical approach in the treatment of pelvic organ prolapse. Pessaries are sometimes employed to test the effect of surgery for pelvic organ prolapse upon urinary incontinence symptoms. Pessaries are very effective in the treatment of uterine prolapse in young women during pregnancy. In this case, the pessary works by holding the uterus in a correct position before it enlarges and prolapses in-to the vagina. Pregnancy, childbirth, and difficult labor are factors that weaken pelvic muscles in some women. Also, with increasing age, due to deficiency of estrogen, tightness of muscles gets reduced slowly. This may lead to drop of the uterus in-to the vaginal canal. Apart from this, factors such as chronic cough, obesity, and hormonal disturbances cause pelvic floor drop.

Report Overview @ https://www.transparencymarketresearch.com/vaginal-pessaries-market.html

According to the U.S. Census Bureau, the number of women aged 65 years and above in America would double by 2030 to reach over 40 million. Increasing geriatric population, increasing incidence of pelvic organ prolapse, and changing lifestyles are factors driving the vaginal pessaries market. However, complications caused by use of pessaries such as formation of an opening between the vagina and the rectum, bleeding, open sores, and irritation are factors hampering the vaginal pessaries market. Pelvic organ prolapse is very common worldwide; however, the number of undiagnosed cases is still high, due to feeling of embarrassment and shyness among patients. Poor diagnosis of the disorder is another restraining factor for the market. Pessaries available at present, lack the ease of insertion and comfort. There exist lucrative opportunities for R&D to develop more flexible and irritation-free pessaries.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28583

The global vaginal pessaries market can be segmented on the basis of physical characteristics, application, and region. Based on physical characteristics, the vaginal pessaries market has been broadly segmented in-to support pessaries and space-occupying pessaries. Support pessaries are further classified as ring pessaries, gehrungs, and mar-lands. Ring pessaries are of two types, those with and without support and those with a knob to help in urinary incontinence. Ring pessaries is a preferred choice of clinicians, due to its ease of insertion and removal of these pessaries. These are best suited for earlier stages of prolapse, but can also be applied in all stages of pelvic organ prolapse. Gehrungs are the pessaries useful for the control of third stage uterine prolapse accompanied by cystocele or rectocele. Gehrung rests on the vaginal wall like a bridge. Mar-land is a flexible silicone pessary useful against minor prolapse and for relieving the stress caused by incontinence. Space-occupying pessaries are further classified in-to shelf pessaries, gellhorn pessaries, donut pessaries, incontinence dish pessaries with knobs, hodge pessaries, and cube pessaries. Shelf pessaries are flat and kidney-shaped with a raised handle. Gellhorn pessaries are used against advanced stages of prolapse and in patients who are not sexually active. Donut pessaries are employed to relieve the cystocele or rectocele and second or third stage uterine prolapse. Cube pessaries are effective in the control of stage-III and stage-IV prolapse.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=28583

Based on application, the vaginal pessaries market can be segmented in-to therapeutic pessaries, pharmaceutical pessaries, and occlusive pessaries. Therapeutic pessary is a medical device applied to support the pelvic organs. Pharmaceutical pessaries are used to deliver drugs to vagina. These are very effective in the treatment of local inflammations and yeast infections. Occlusive pessaries, when combined with spermicides, act as an effective means of contraception.

Geographically, the global vaginal pessaries market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for a major share of the global vaginal pessaries market. Research indicates, in 2010, there were 3.3 million women suffering from pelvic organ prolapse in U.S. alone. Increasing geriatric women population, lifestyle changes leading to hormonal disturbances, rising prevalence of pelvic organ prolapse, and awareness about health are factors driving the market in North America. The region is followed by Europe. The market in Europe is expanding at a significant pace. This is attributable to high expenditure on health care, and favorable reimbursement scenario in the region. The market in Asia Pacific is expected to expand rapidly during forecast period.

Key players operating in the global vaginal pessaries market are Cooper Surgical Inc., MedGyn Products, Inc., Personal Medical Corp., Panpac Medical Corp, Smiths Medical, and Thomas Medical among others.

Popular Research Reports by TMR:

Interstitial Cystitis Market: Global Segments, Top Key Players, Size and Recent Trends by Forecast to 2025

Interstitial cystitis (IC), also known as painful bladder syndrome, is a chronic bladder issue often associated with bladder pressure and pain, with occasional pain in either the lower abdomen, pelvic, or lower back. The patient could experience pain raging from mild to severe. The pelvic nerve signal to the brain gets mixed up in an individual suffering from interstitial cystitis. Consequently, an urgency to urinate, often in a small volume, is observed. On an average, a person urinates seven times a day; however, in severe cases of IC, urination may occur around 40-60 times a day. IC is not an infection, but is often mistaken to be a bladder infection. Factors contributing to interstitial cystitis are: a defect of the epithelium layer of the bladder, leaking epithelium allows toxic agents in urine to irritate the bladder wall. Other anticipated, but not clear, contributing factors include heredity, an autoimmune reaction, infection or allergy. Various therapies and medication may provide relief from the symptoms for IC; however, there is still no cure for this disease.

Report Overview @ https://www.transparencymarketresearch.com/interstitial-cystitis-market.html

Studies conducted on interstitial cystitis and associated data have shown that it is thrice more prevalent in women than in men, and the risk increases with age. The female-to-male ratio is estimated to be 10:1. It is estimated that around 1 to4 million men and 3 to8 million women suffer from IC. Rise in prevalence of IC stimulates the research and development on the drug, as it is likely to provide an appropriate environment for newer products to be profitable. The prevalence of IC is estimated to be between 2.7% to 6.53% among older women in the United States. Patients suffering from other conditions such as fibromyalgia, irritable bowel syndrome, or allergies often experience IC. According to a publication by National Institutes of Health (NIH), in 2012, the annual expenditure for medication for the geriatric population aged ≥65 years who are Medicare beneficiaries was US$ 249,160,233 (nonspecific and specific IC combined).

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25523

IC is mainly diagnosed by urine analysis, bladder ultrasound, cystoscopy, biopsy of bladder and urethra, bladder stretching, and prostrate fluid culture. The main goal is to relieve the symptoms of IC, and thus treatment is segmented into five phases: First phase by Physical therapy, second phase treatment by oral medication such as Amitriptyline – to regulate the bladder spasms, Pentosan (Elmiron) – helps rebuild the tissue lining the bladder, hydroxyzine, use of steroids, and dimethyl sulfoxide to treat severe IC conditions by blocking the pain and reducing the inflammation is also recommended. The third phase is neurostimulation – transcutaneous electrical nerve stimulation or sacral nerve stimulation. The fourth phase includes administering cyclosporine to alter the immune response on the bladder, and the fifth phase involves bladder detention or surgery. The market currently has only two approved treatment options for IC: Elmiron (pentosan polysulfate sodium) and Rimso-50 (dimethyl sulfoxide). Elmiron was approved on September 26, 1996, and its patent expired on January 19, 2010. Similarly, Rimso-50 was approved prior to January 1, 1982, and its patent expired before 2002. The current line of treatment is dominated by off-label drug options such as antidepressants (amitriptyline), antihistamines (hydroxyzine), and analgesics (opioid and non-steroidal) due to the limited availability of approved therapies.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=25523

The IC therapeutics market is currently weak due to limitations regarding the efficacy and compliance of available products. Other factors contributing to the significant unmet needs include limited approved treatment options, lack of awareness, and need for disease modifying therapies. Current pipeline for the IC therapeutics market is very weak with a majority of the molecules in the early stage of development. These significant unmet needs and weak pipeline with a majority of the molecules in early stage pose new opportunities for new entrants.

In terms of geography, the interstitial cystitis market can be segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). The interstitial cystitis market is estimated to expand at a sluggish rate primarily due to the limited availability of approved products, low diagnosis rate, and lack of new product approvals.

Key players operating in the interstitial cystitis market are Aquinox Pharmaceuticals Inc., Astellas Pharma Inc, Merck & Co Inc, Allergan Plc., Kytogenics Pharmaceuticals Inc., BELLUS Health Inc, UCB SA, Lipella Pharmaceuticals Inc, Urigen Pharmaceuticals Inc, and Xigen SA.

Surgical Microscopes Market Emerging Technologies, Regional Trends, Competitive Landscape, Regional Analysis & Forecasts to 2025

A surgical microscope or operating microscope is an electrically or mechanically operated optical microscope designed specifically to perform microsurgeries in a surgical setting. It provides magnification (typically ranging from 4x–40x), illuminated image, and stereoscopic vision of the surgical area. Surgical microscopes mainly offer a strain-free procedure to surgeons. Their components are designed to sterilize or disinfect easily to avoid cross infection. The modern operating or surgical microscope can be placed on a surface such as a table top, mounted on a stand, or worn by the surgeon on the head. In a surgical suite with limited space, it can be hung on the wall or ceiling to conserve floor space. It enables students, staff, as well as the patient to gain a better view of the target site, along with the surgeon.

Report Overview @ https://www.transparencymarketresearch.com/surgical-microscopes-market.html

The global surgical microscope market is expected to develop substantially due to the rising prevalence of chronic diseases and adoption of microsurgeries or minimally invasive surgeries. Demand for them is predicted to drive the market for surgical microscopes as they play a critical role in these surgeries. The geriatric population is highly susceptible to several chronic disorders and age-related problems, which is likely to aid the expansion of the market. Furthermore, advancements in health care infrastructure and research & development in life sciences are predicted to drive the market. Rapid technological advancements in surgical microscopes regarding visibility, portability, stability, adoption of fluorescence image-guided surgery (FIGS), and addition of innovative features such as the red reflex stability, augmented microscopy, and wide angle view are anticipated to propel the market during the forecast period.

However, the high cost of the microscope leading to its low acceptance may restrain the market in some regions, apart from the heavy custom duties on medical instruments and excise tax implementations by the U.S. government. The dearth of skilled professionals and inadequate technical knowledge may lead to sluggish development of the global surgical microscope market.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23702

The market can be segmented on the basis of application into the following categories: ophthalmic surgeries, neurosurgery, ENT surgeries, plastic & reconstructive surgery, spine surgery, dentistry, gynecology (also colposcopes for diagnostics in gynecologic treatments), and urology. Ophthalmology is the dominant segment due to growing concerns over vision & eyesight, increasing prevalence of eye disorders, and rising population opting for ophthalmology surgeries globally. The ENT segment is projected to advance significantly owing to the mounting preference for minimally invasive surgeries for ENT, high prevalence of disorders such as sinusitis, and supportive reimbursement plans. In terms of end-user, the global surgical microscope market can be divided into the following groups: hospitals, specialty clinics, and ambulatory surgical centers.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=23702

Geographically, the market can be distributed over five major regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the surgical microscope market, owing to the sophisticated health care services and supportive reimbursement policies for medical treatments enabling greater usage of the instrument in the region. Moreover, the rising incidence of chronic diseases and higher adoption of minimally invasive surgeries play a role too. Asia Pacific is estimated to expand rapidly on account of the increasing geriatric population, advancements in health care facilities, and supportive medical reimbursement programs in emerging countries such as India and China. Asia Pacific and Latin America are lucrative target areas for major key players of the surgical microscope market.

These include Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Topcon Medical Systems, Inc. (Topcon Corporation), Haag-Streit Group, Novartis AG, Takagi Seiko Co Ltd., and Global Surgical Corporation.

Motility Testing Market: Size, Share, Emerging Trends, Analysis and Forecasts to 2027

Motility Testing is a test used to determine the motility of the microorganism based on the microscopic observation that can propel themselves through liquids. Motility Testing helps to understand the biochemical process of hydrogen sulfide production by bacteria. Motility is closely linked with chemotaxis i.e. the ability to orientate along certain chemical gradients. The capacity for self-propulsion or actual motility is present in various types of cells, but not true for all. However, some non-motile bacteria in an aqueous environment appear to be moving erratically; this is due to the random motion of the water molecules bombarding the bacteria and causing them to move. There are the variety of ways to determine the motility of an organism- Microscopic Analysis and Biochemical Tests. Microscopy method is preferable over Biochemical Tests as it helps to determine the motility in a more accurate way with a number of flagella on an organism. Motility Testing is done when the person experiences some symptoms like nausea, constipation, bloating, vomiting, abdominal pain or various disorders. Owing to the continuous increase in the population exhibiting Infectious Disease and symptoms, the market for Motility Testing is expected to witness robust growth over the forecast period.

Report Overview @ https://www.transparencymarketresearch.com/motility-testing-market.html

Motility Testing Market: Drivers and Restraints

The ongoing technical advancements in precise accuracy and speed of microbial identification Equipment coupled growing number of diseases due to harmful microorganism are some of the dominant drivers for the Motility Testing market. The growth is likely to continue with the aim of providing contemptible and efficient methods for determining cellular shape and arrangement of a bacteria for motility and closer to patient’s care which is expected to boost Motility Testing market in upcoming years. On the Contrary, Risk to a person while handling viable organism or pathogen on a slide, problems associated with the readings as slide quickly dries out, rendering the organism immotile and sometimes long processing time is putting the challenge for the overall growth of global Motility Testing market.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22736

Motility Testing Market: Overview

Global trends of making healthcare service more patient-centric than the service provider show expanding growing opportunities for Motility testing, as there are lots of funding available from multiple sources including NIH, as well as various private foundations and government. The Motility testing includes different types of slide methods such as wet mount slide, hanging drop slide, soft agar stabbing, etc. Motility Testing is also done to test male fertility for verifying the success of vasectomy or for couple infertility check. Rising demand for sperm motility is expected to fuel the market for Motility Testing over the forecast period.

Motility Testing Market: Region-wise Outlook

A geographic condition regarding for Motility Testing market, it has been segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, and Middle East & Africa. North America is the largest market for Motility Testing market followed by Europe due to the technological or medical advancements in terms of new diagnostic equipment and diagnostic procedures for Motility Testing and developed healthcare facilities. Asia Pacific is exhibiting the highest growth over the past few years attributed mainly to the rising consumer’s concern towards health and food safety. Moreover, the government initiative to develop various laboratories to perform high-quality motility screening procedures for the evaluation of patient would also propel the Motility Testing market growth during the forecast period.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=22736

Motility Testing Market: Key Market Participants

Major players in the Motility Testing market include: Medtronic, Laborie,

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Colposcope Market Business Growth, Development Factors, Applications, and Future Prospects

Colposcope is a type of microscope which has lens with light source to observe and examine the uterine cervix. The colposcope is employed to observe and identify abnormal tissue or blood vessel development in the vagina and around the cervix. Furthermore, it helps obtain tissue samples for biopsy intended to diagnose cancer. Colposcope presents a large and detailed view of the various parts of the uterus, helping doctors and healthcare professionals to visually differentiate between a normal and abnormal noticeable tissue. Subsequently, if necessary, they can forward it to the laboratory for further pathological evaluation and investigation by taking directed biopsies. The important application of colposcopy is to avoid cervical cancer by detecting pre-cancerous tumor cells early and treating cancer in the early stage. Colposcope, which is fitted with a specialized camera, is also utilized in identifying and collecting evidence for a victim of sexual assault and rape. Additionally, it is employed to examine various problems related to the uterus. A colposcope is used to examine visible abnormal tissue. Its working mechanism is similar to that of a monocular microscope or lighted binocular. Its function is to present an enlarged and magnified view of the vagina, cervix, and vulvar surface. Coloscopy also has certain drawbacks and complications, which may include bleeding, failure to identify the lesion, and infection at the biopsy site or endometrium.

Report Overview @ https://www.transparencymarketresearch.com/colposcope-market.html

A number of factors affect the growth of the colposcope market. Key factors affecting the expansion of the colposcope market include rising demand for colposcope for diagnosis, development and advancement in colposcope devices, increasing number of the cervical cancer patients, and rise in global geriatric population. Other key drivers are technological advancement in diagnostic devices, increase in the number of diagnosis procedures, and rise in the number of uterus problems related to the elderly population. The market is also witnessing restraints or challenges such as development of other diagnostic procedures and technologies and stiff competition among existing colposcope device manufacturers. Moreover, product recalls, government regulations for reduction of overall health care cost, and subsequent upswing in bulk purchasing through INHs and GPOs (Group Purchasing Organizations) are restraining the market.

Request Brochure @ https://www.transparencymarketresearch.com/colposcope-market.html

The colposcope market can be segmented into product type, end-user, and region. In terms of product type, the market can be segmented into optical colposcope, video colposcope, accessories, and consumables. The accessories segment can be further segmented into camera, display, and others. The video colposcope segment holds significant share of the market. In terms of end-user, the market can be segmented into hospitals, gynecology clinics, diagnostic centers, and research & academics. The hospitals segment dominates the colposcope market.

In terms of geography, the colposcope market can be segmented into five major regions: North America (U.S. and Canada), Europe (Germany, France, U.K., etc.), Asia Pacific (Australia, New Zealand, China, Japan, India, etc.), Latin America (Brazil, Mexico, etc.), and Middle East & Africa (GCC Countries, Saudi Arabia, South Africa, etc.). North America holds prominent share of the market due to advanced technology in the region. The emerging markets in Asia Pacific, Latin America, and Middle East & Africa are estimated to expand considerably during the forecast period from 2017 to 2025. This is attributed to increasing prevalence of the cervical cancer, increasing investments by key players operating in these countries, expanding health care industry, and the aging population leading to increase in the patient population in these countries. India, China, and Brazil are expected to fuel expansion of the market due to increasing investments by government bodies to enhance health care facilities.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=22901

Key companies operating in the global colposcope market are CooperSurgical, Inc., Edan Instruments, Inc., MedGyn Products, Inc., Wallach Surgical Devices, Kernel Medical Equipment Co., Ltd, Seiler Instrument Inc., Gynex Corporation, and ZEISS Group

Urethra Cystoscopes Market Key Manufacturers, Development Trends And Competitive Analysis 2024

Cystoscopy is an invaluable tool for identifying lower urinary tract complications or disorders and is the most common procedure performed in urology. Cystoscopes are commonly used to investigate the inside of the urinary tract. Cystoscopes are classified as semi-critical devices, according to the Spaulding classification system, for medical devices and disinfection, proposed by Dr. E H Spaulding. Cystoscopy is generally used for diagnosis and monitoring progress of conditions or diseases. It also helps in ruling out certain symptoms, thereby enabling further medical interventions. For example, routine cystoscopy is carried out before and after the treatment of bladder cancer to check for reoccurrence of tumor to prevent its further spread.

Urethra cystoscope is used to look inside of urethra, which is a part of urinary tract. It is a long and thin optical instrument. At one end, it has an eyepiece, a flexible or rigid tube at the center, and the other end of the tube has tiny lens and light.

Report Overview @ https://www.transparencymarketresearch.com/urethra-cystoscopes-market.html

Cystoscopy is carried out by urologists in order to relate the cause of symptoms for urinary tract problems such as frequent episodes of urine or urinary tract infections, hematuria, urinary incontinence, pain, burning or any kind of discomfort at urinary site, abnormal cells in urine, etc. Cystoscopy is also carried out to detect and remove renal or urinary stones, abnormal tissues, polyps or tumors in urethra. These can assist in other purposes such as removal of stent and performing retrograde pyelography.

The most important task in use of urethra cystoscopes is sterilizing or reprocessing in between patients, and very few are found to address the reprocessing as per the requirement. Hence, proper training is required for urologist to carry out urethra cystoscopy. Major risk associated with the use of urethra cystoscopes is acquisition of urinary tract infection as a urethra cystoscope is reused many times. Other risks include urethral bleeding or pain, as well as fever in some cases.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20957

Major drivers of the urethra cystoscopes market are rise in urethra related disorders or diseases such as bladder cancer and renal stones and applications in several medical procedures such as stent insertion and dye insertion. Other factors such as urethral cytoscope flexibility, minimal invasive technique, and increase in health awareness and improvement in health care facilities propel the urethra cystoscopies market. Major restraint of the urethra cystoscopes market is risk of transmission of infection, especially urinary tract infection. High maintenance and sterility required for use of urethra cytoscopes and emergence of new endoscopic techniques such as endoscopic capsules are likely to hamper the market. Manufacturers are developing advanced urethra cytoscopes to increase flexibility and enhance visibility during cystoscopy. This is likely to provide significant opportunity in the near future.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=20957

The urethra cystoscopes market has been segmented based on product type, application, disinfection type, end-user, and region. In terms of product type, the market has been segmented into flexible urethra cytoscopes, rigid urethra cytoscopes, and consumables. Based on application, the urethra cystoscopes market has been categorized into urinary tract infection (UTI) diagnosis, biopsy, and others. Other applications include removal of renal stones, lumps, or tumors. In terms of disinfection type, the urethra cystoscopes market has been classified into manual and automated. Based on end-user, the market has been segmented into hospitals, specialized clinical laboratories, and research institutions. In terms of region, the urethra cystoscopes market has been classified into Asia Pacific, Europe, Middle East & Africa, North America, and Latin America.

Major players in the urethra cystoscopes market are Olympus Medical Systems Corporation, Medtronic plc, Boston Scientific, Stryker Corporation, Richard Wolf GmbH, Shenda Endoscope, Zhejiang Tiansong Medical Instrument Co., Ltd., Henke-Sass, Wolf GmbH, and Pentax Medical System, among others.

Thursday, November 29, 2018

Pedometer Market Growth, Capacity, Scope, Revenue, Key-Players, and Forecast until 2025

A pedometer, also called step counter, is a small pager-type device which counts the number of steps taken by the wearer, or human body, during a specified time. It is usually worn at the waist or above the knee. A pedometer is used to measure everyday physical activity and motivates the person to perform a higher level of physical activity such as walking, running, and jogging. Pedometers can be analog devices, which measure steps, while some can be digital models that measure the distance covered and calories burned while performing any physical activity. Calorie counters are more expensive and less accurate. The pedometer records each step, which is recorded, by measuring the hip movement. Pedometers are always more accurate in recording fast walking than slow walking. A pedometer records all activities including running, walking, or climbing stairs. However, it counts the number of steps only, and not the intensity of those steps. Major physical activities where pedometers are used are walking, running, jogging, and climbing stairs.

Report Overview @ https://www.transparencymarketresearch.com/pedometer-market.html

Pedometers are simple, easy to operate, inexpensive, and provide accurate and reliable results. They are powered by a small battery, which is designed to last for a long duration. The major advantage of a pedometer is the immediate results which are provided on physical activity and exercise, which motivates the wearer to set goals for daily physical activity in order to have a healthy body. Pedometers are small, lightweight, and almost anyone can wear it, from children to adults to elderly people. Increase in healthcare issues, awareness regarding healthy lifestyle, physical exercise awareness campaigns, and technological advancement through connection of pedometer with digital world are the major factors driving the global pedometer market. A large population suffering from lifestyle related diseases and preventable welfare diseases has created significant awareness regarding importance of physical activity in achieving good health and reducing chronic diseases. Rising physical activity and new technological advancements in the connecting pedometer with a cell phone/ smartphone is fuelling the expansion of the pedometer market.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26774

The global pedometer market has been segmented into product, distribution channel, and region. In terms of product type, the pedometer market can be segmented into piezoelectric and spring-levered. Spring-levered pedometers employ a spring-suspended horizontal lever arm which moves in response to the vertical movement of hips, as one is walking or running. A piezoelectric pedometer generates electric charge when subjected to movement, which in turn generates voltage proportional to the acceleration, and the voltage oscillations are used to record steps. The piezoelectric pedometer tends to be preferred more than the spring levered pedometer, as it is more sensitive and is not position dependent. In terms of distribution channel, the market can be segmented into online, retail store, supermarkets, and others

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=26774

In terms of geography, the global pedometer market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for a major share of the pedometer market. Increased awareness about physical activity, adoption of connected devices, increase in product range from key players, and new wearable portable pedometers are some factors propelling the expansion of the pedometer market in the region. Increased adoption of wearable devices is also a key factor fueling the expansion of the market. Rise in number of lifestyle diseases, increase in number of chronic diseases, rising awareness about physical activity benefits, and low cost of pedometer devices are further fueling the expansion of the pedometer market in developing countries of Asia Pacific. The market in the region is likely to expand at a significant CAGR in the near future.

Key players operating in the global pedometer market include WeLoop, Huawei Technologies Co., Ltd, Lifesense Group, Xiaomi Inc., Fitbit, Inc., NIKE, Inc., Jawbone, OMRON Corporation, and iWOWNfit and others.

Popular Research Reports by TMR:

Pigmentation Disorders Treatment Market: https://www.prnewswire.com/news-releases/global-pigmentation-disorders-treatment-market-to-reach-us-9-268-6-mn-by-2026-rise-in-awareness-about-skin-rejuvenation-are-likely-to-boost-demand-transparency-market-research-828363328.html

Pediatric Medical Devices Market : https://www.prnewswire.com/news-releases/pediatric-medical-devices-market-to-become-worth-us-41-000-mn-by-2026-says-tmr-836720209.html

Spinal Image Guidance Systems Market Future Opportunities 2025

Image guidance is a surgical technology that allows intraoperative navigation of surgical instruments relative to imaging studies. Advancement in this technology has increased the safety, accuracy, and efficiency of certain procedures in spinal surgery. This technique is increasingly utilized for spinal surgeries. The spinal image guidance system enables surgeons to see a patient’s anatomy before and after a procedure in three dimensions and in real time. This technology is used to create a three-dimensional model of the patient’s spine which is displayed on a computer screen. An image guidance technology is a combination of X-ray and computer technology. This technology allows surgeons to see virtual images of the surgical instruments used during surgeries, helping surgeons to analyze complex procedures. Research studies have shown the use of this technology to increase precision of pedicle screw placement.

Report Overview @ https://www.transparencymarketresearch.com/spinal-image-guidance-systems-market.html

Increase incidences of spinal injuries due to fractures, tumors, and conditions such as ankylosing spondylitis and scoliosis are driving the growth of the global market for spinal image guidance systems. Studies have shown that the growing risk of cancers has led to a rise in complications related to spinal disorders, increasing the market opportunities of spinal image guidance systems. Moreover, bone changes with growing age such as spinal stenosis and herniated disks have facilitated the market growth. The use of robotics and automated system for spinal surgeries has boosted the spinal image guidance systems market. However, high cost of this technology and lack of trained surgeons to perform these surgeries are some of the major restraints for the growth of the market.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26654

The spinal image guidance systems market can be segmented on the basis of technology, end-user, and region. In terms of technology, the market can be segmented as X-ray, magnetic resonance imaging (MRI), computed tomography (CT), 3D fluoroscopy technique, cone beam CT based navigation, and intraoperative CT based navigation. The X-ray system with live image guidance provides a high-quality image and ease of use. Currently, these systems are used for posterior spinal surgeries. The computed tomography is the most commonly used system for spinal image guidance. Computed tomography scan or magnetic resonance imaging is used in diagnostic testing prior to an image guided spinal operation. High prevalence of spinal disorders is increasing the demand for spinal image guidance systems.

On the basis of end-user, the market can be segmented as hospitals, ambulatory surgical centers, diagnostic centers, and others. Among these, the hospitals and diagnostic centers segments contribute a significant market share. Hospitals are investing large amounts in purchasing these technologies for accurate and satisfying results.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=26654

Geographically, the global market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the market owing to better economy and development in health care facilities. Europe holds the second largest market share for spinal image guidance systems. Increasing investments by various governments and private organizations in the health care sector are projected to boost the market growth in Asia Pacific and other regions of the world.

The key players operating in the spinal image guidance systems market include GE Healthcare, Siemens Healthcare, Philips Health, Medtronic Sofamor Danek, Tyco, 7D Surgical Systems, Sulzer, and Ohio Medical.

Popular Research Reports by TMR:

Central Nervous System (CNS) Biomarkers Market Key Manufacturers, Development Trends And Competitive Analysis 2024

Global Central Nervous System (CNS) Biomarkers Market: Overview

Biomarkers are measurable biological indicators that are used to diagnose or predict diseases, examine disease progression, and estimate treatment response. Biomarkers help in understanding the development of chronic diseases, its relationship with environmental chemicals, and identify subjects who are at high risk of developing disease. For several years, biomarkers have played a significant role in drug research and development of new drugs and in diagnostics. Moreover, biomarkers play important role in understanding disease mechanism, developing effective treatments, and improve quality of patient care.

Report Overview @ https://www.transparencymarketresearch.com/cns-biomarkers-market.html

The development in related technologies, such as genomics, proteomics, and imaging system, has reflected on evolution of newer biomarkers. Considering the complexity of central nervous system (CNS), biomarkers are now expected to play a significant role in identification of several neurodegenerative diseases at early stage, provide enhanced diagnosis, and eventually better treatment. Consequently, the global market for central nervous system (CNS) biomarkers is projected for a double digit growth rate during the forecast period of 2016 to 2024. To provide a complete picture of the market, this report divides it into lucrative segments and also profiles some of the key players for their market share, product portfolio, and development strategies.

The global CNS biomarkers market can be segmented on the basis of application, type, end user and geography. By application, the market can be divided into diagnostic development, personalized medicine drug discovery and development, and disease risk assessment. All of these segments are in high demand, contributing significantly in the growth of CNS biomarkers market.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1622

Global Central Nervous System (CNS) Biomarkers Market: Trends and Opportunities

The report picks out the development in proteomics, genomics, and imaging system as the primary driver in the market. These developments has led to increased investment from government and private players, which is further fueling market. Moreover, the rise in diseases such as cancer, cardiovascular diseases (CVD), coronary heart disease (CHD), and other heart related diseases is another favorable factor for the market. Some of the other drivers highlighted by the report are: favorable government policies and regulations, successful clinical trials of several biomarkers, and FDA’s approval to CNS biomarker drugs.

Conversely, the report highlights two factors which may hinder the growth rate during the forecast period, which are the high cost of CNS biomarker tests and diagnostics and unclear reimbursement policies in many prospect country-wide markets. Untapped market in Asia Pacific is projected as an opportunity for players to invest with long-term prospects.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1622

Global Central Nervous System (CNS) Biomarkers Market: Region-wise Outlook

Geographically, this market can be divided into the regions of North America, Europe, Asia Pacific, and rest the world. Currently, North America contributes to the maximum demand, owning to the rise in life-style oriented diseases such as cancer, stroke, and other heart diseases. In 2014, Europe served the second most significant demand but the emerging economies of China, India, Japan, and Korea are expected to turn Asia Pacific into a highly lucrative market during the course of the forecast period. These countries are aggressively investing in improving their healthcare spending, and have skilled labor at affordable cost. This as a result is creating immense opportunities for the players who are willing to take initiative.

Companies mentioned in the research report

The key players in global central nervous system biomarkers market include Thermo fisher scientific, Enzo biochem inc, Abiant Inc, EKF diagnostics holdings Inc, Abastar MDX Inc, Acumen pharmaceuticals Inc, Adlyfe Inc, Apitope international, Alseres pharmaceuticals Inc, Aposense, Banyan biomarkers, Avid radiopharmaceuticals Inc, Diagenic ASA, Avacta group plc, Applied neurosolutions Inc, Merc & co. Inc, and Exonhit therapeutics. The players strategically invest on research and development for innovative and technological advancements, and focus on partnerships with domestic players to expand their outreach.

Hybrid Imaging Systems Market: Overview with Detailed Analysis, Competitive landscape Forecast to 2025

Hybrid imaging is fusion of two or more imaging technologies into a single new form. The image obtained with hybrid imaging system is more powerful in terms of accuracy as compared to two single images. Along with depicting the anatomy, hybrid imaging enables visualization of the molecular processes in vivo within larger anatomic content. Technologies in hybrid imaging include ultrasonography, magnetic resonance imagining (MRI), computed tomography (CT), and positron emission tomography (PET). The fusion of these technologies have given rise to hybrid imaging systems. The hybrid of PET/CT was introduced in 2001 and SPECT/CT was introduced in 2003. PET/MRI is also an available hybrid imaging system, but not used widely. Both hybrid imaging techniques PET/CT and SPECT/CT have significant relevance in clinical and pre-clinical practice. Hybrid imaging scans need a patient to be stationed at the same place for both scans. Involuntary movements of the internal organs can be minimized in hybrid imaging systems. Hybrid imaging systems have reduced the time required for scanning. Usually the required time with standalone imaging systems is an hour or even more. However, hybrid imaging systems have reduced scanning time by up to 25 minutes to 30 minutes. With the emergence of hybrid imaging system, a patient can be scanned in a single session and the desired anatomical and functional data of the organ of interest can be achieved. PET/CT has evolved due to continuous innovation, which enables more accurate measurements of metabolic processes, data quantification and analysis of neurologic disease, cancerous tissue, and cardiac blood flow. PET/CT is a standard hybrid imaging technique used in oncology and SPECT/CT, which is in an evolving phase, is generally used for cardiac scans.

Report Overview @ https://www.transparencymarketresearch.com/hybrid-imaging-systems-market.html

Rise in importance of combination analysis of anatomic and molecular data in the diagnosis of diseases is a major driver of the global hybrid imaging systems market. Further with the benefits of hybrid imaging and its rising use in the diagnosis, there is huge potential for the of combination hybrid imaging PET or SPECT with MRI. Increase in prevalence of chronic diseases, growing awareness about early diagnosis, and rise in the number of diagnostic procedures are propelling the market. Site accreditation, technologist training, physician training, and high cost for procedure among the underprivileged population are the major restraints of the global hybrid imaging systems market.

The global hybrid imaging systems market can be segmented based on technology, application, end-user, and region. In terms of technology, the market can be categorized into PET/CT, SPECT/CT, and PET/MRI. By applications the segment PET/CT scan, used for diagnosis in the field of oncology, neurology and cardiology, whereas, SPECT/CT scans are done for the diagnosis of infections, inflammation, thyroid disorders, oncology and orthopedic problems. In terms of end-user, the market can be bifurcated into hospitals and diagnostic centers. In terms of region, the global hybrid imaging systems market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35696

In the past five years, standalone systems have been replaced by hybrid imaging systems, a trend observed globally. Highest number of installations of PET/CT were seen in the U.S. Western Europe reported increase in PET/CT scans by 72% in 2008; installations of SPECT/CT were lesser than PET/CT. The Middle East is an emerging market for hybrid imaging systems. In North America, hybrid scanning system is highly preferred in the diagnosis of cardiology and global nuclear medicine market. This trend is also predominant in Europe and Asia Pacific. Countries in Asia are also expected to witness growth in the next few years due to rise in awareness about early diagnosis of life threatening diseases and advancements in nuclear medicine. Latin America and Middle East & Africa are potential markets. Growth in these regions is attributed to low disposable income and significant contribution of government investment in health care.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=35696

Leading players in the global hybrid imaging systems market are Siemens Healthineers, GE Healthcare, Philips Healthcare, Hitachi Ltd., Atlantis Worldwide, Shared Imaging, and Amber Diagnostic, Inc.

Popular Research Reports by TMR:

Operating Room Equipment Market: http://www.prnewswire.co.uk/news-releases/operating-room-equipment-market-to-generate-us428733-million-revenue-by-2026-says-tmr-691005331.html

Viral Inactivation Market: https://globenewswire.com/news-release/2018/08/24/1556475/0/en/Viral-Inactivation-Market-is-Projected-to-Surpass-US-5-736-bn-by-2025-Says-TMR.html

Medical Electronics Market Will Generate New Growth Opportunities By 2025

Electronic devices are increasingly used for therapy, diagnosis, and rehabilitation in the field of medicine. Electromechanical equipment and medical electronics have become indispensable for providing better services to patients. Medical electronics is a branch of electronics in which medical equipment and instruments are used for medical applications such as research, diagnosis, therapy, anesthesia control, surgery, and cardiac control. Medical electronics engineering integrates medicine and environmental science with engineering practices and theories. Semiconductors have become an integral part of medical electronics equipment for reducing the cost which is changing the affordability of equipments. Medical electronic equipment are indispensable for proving better services to patients in hospitals. In medical electronics by using precise and sophisticated equipment, medical science examines, cures and treats almost all the diseases. Benefits associated with the use of medical electronic technologies include remote health data availability, precise billing mechanism, improvement in the quality of health care, increase in output accuracy, easy to update patient records, and rise in the level of patient experience. Rapid advancement in IT and increasing health care consciousness has accelerated the scope for medical electronics market. Advanced technology in medical electronics include telehealth in intensive care unit (ICU), emergency department (ED) and hospital ward and skilled nursing facility (SNF). With the advent of digital stethoscopes, digital X-ray systems and handheld smart phone-sized ultrasound systems, conventional medical devices have evolved to aid medical electronics market. Rapid advancement in health care consciousness and information technology has accelerated the scope for medical electronics market. Growth in medical electronics market is influencing various demographic trends such as enhanced portability of complex monitoring and imaging systems, increase in household medical electronics equipment, and functional integration of applications and equipment in network and wireless technology.

Report Overview @ https://www.transparencymarketresearch.com/medical-electronics-market.html

Rising geriatric population and increasing use of respiratory care devices are fuelling the medical electronics market. Additionally, factors such as demand for easy-to-use, personalized & advanced healthcare devices, changing lifestyle, and rising adoption of wearable electronics are expected to drive the medical electronics market. However, issues regarding cybersecurity, where health care providers and patients are subjected to security breaches and malware infections are expected to hinder the market. Rising demand for better and improved health care and developments in newer medical technologies for wireless medical devices and its technology are expected boost the medical electronics market. Moreover, factors such as increased market penetration rate of portable medical devices, increasing trend of remote patient monitoring, and high availability of electronic components such as memory devices, display technologies and microcontrollers are expected to create growth opportunities for medical electronics market. With advancement in technology, newer medical electronics devices are emerging in healthcare which is also expected to boost growth in medical electronics market.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34568

The global medical electronics market can be segmented based on product type, application, component, and region. In terms of product type, the market can be segmented into invasive and non-invasive. Based on application, the market is classified into diagnosis, monitoring, and treatment. In terms of component, the market is categorized into sensors, batteries, memory devices, microcontrollers, and displays. Based on geography the global medical electronics market is segmented into North America, Asia Pacific, Middle-East & Africa (MEA), South America, and Europe. North America is expected to dominate the market during the forecast period owing to the increase in demand for medical electronics and improved health care infrastructure.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=34568

Key players operating in the global medical electronics market are Texas Instruments Inc., GE Healthcare Pvt. Ltd, STMicroelectronics N.V., NXP Semiconductors N.V., Medtronic PLC., Cypress Semiconductor Corporation, Analog Devices, Inc., On Semiconductor Corporation, Siemens Healthcare Private Limited, and Philips Healthcare Pvt. Ltd.

Popular Research Reports by TMR:

Arterial Cannulae Market: Analysis and Research Report by Experts 2025

Arterial cannulae are used during cardiopulmonary bypass (CPB) in perfusion of the ascending aorta. These are made up of different materials such as biocompatible material, silicone, polyurethane, polyvinyl chloride (PVC), and others. All cannulae are usually flexible, transparent with rigid tips or smooth plastic tips, and with or without a connector. The tip of a cannula can be straight or curved. It has a vent plug for de-airing of the cannula during the cannulation. Some cannulae have features such as wire-reinforcement, which diminish the risk of kinking and reducing wall thickness.

Report Overview @ https://www.transparencymarketresearch.com/arterial-cannulae-market.html

The growth of the global arterial cannulae market is driven by the rise in incidence of cardiopulmonary disorders, leading to a rising number of bypass procedures performed worldwide. In addition, rising health care expenditure, advancement in health care facilities in developing countries, and sedentary lifestyle of general population leading to cardiac diseases and obesity are the major factors driving the market growth of arterial cannulae. However, rising cost of equipment and lack of skilled physicians to perform surgeries are key factors which are hampering the growth of the global arterial cannulae market. On the other hand, penetration of regional local players with low cost devices is likely to drive the growth of the market in emerging economies. Technological advancements and innovations in the arterial cannula such as movable suture ring, tapered collar, and straight tip are likely to increase the adoption rate of arterial cannulae during the forecast period.

The global arterial cannulae market has been segmented by product, material, end-user, and region. In terms of product, the market is divided into soft-flow arterial cannulae, optiflow arterial cannulae, and standard arterial cannulae. The soft-flow arterial cannulae are gentle on the aorta, which can be easily inserted, and are intended for use during CPB surgery in the perfusion of the ascending aorta. The optiflow arterial cannulae are designed to have a dispersive tip which helps in the reduction of shear stress on the aortic wall. The optiflow arterial cannulae segment is segmented into straight tips and bent tips. The tips are designed to reduce the pressure of the inlet jet stream on the aorta. This alleviates arterial embolization of atherosclerotic plaques which are the potential cause of stroke. Such technological innovation is likely to drive the growth of the optiflow arterial cannulae segment during the forecast period.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34163

Based on material, the global arterial cannulae market is segmented into biocompatible material, polyurethane, PVC, silicone, and others. In terms of end-user, the market is segmented into hospitals, ambulatory surgical centers, clinics, and others (blood banks and home health care facilities). The hospitals segment held the largest share of the arterial cannulae market as compared to ambulatory surgical centers and others. The significant market share of the hospitals segment is attributed to the growing number of patients suffering from cardiac disorders and increasing health care awareness.

Geographically, the market for arterial cannulae has been distributed over five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the global arterial cannulae market in terms of revenue during the forecast period owing to growing prevalence of cardiovascular diseases due to sedentary lifestyle, increasing adoption of minimally invasive techniques, and rising number of surgeries. However, Asia Pacific is projected to expand at a significant CAGR during the forecast period due to advancement in the health care facilities, increased investment in R&D, large population base suffering from cardiovascular disorders, and rising government funding in the healthcare sector.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=34163

Key players operating in the global arterial cannulae market include MAQUET Holding B.V. & Co. KG, Becton Dickinson, Medtronic Inc., Edwards Lifesciences Corporation, Sorin Group, Braile Biomédica, ANDOCOR n.v., DTR Medical, Medline Industries, Inc., Mortech Industries, and Eurosets.

Popular Research Reports by TMR:

Clinical Diagnosis Automation Market: Global Segments, Top Key Players, Size and Recent Trends by Forecast to 2024

Global Clinical Diagnosis Automation Market: Overview

Clinical diagnosis automation is a part of the laboratory automation process which is a multi-disciplinary strategy for the purpose of capitalizing, optimizing, developing, and researching on the technologies used in clinical diagnosis. This, in turn, helps in enabling improved and new processes. The clinical diagnosis automation professionals are medical engineers, scientists, government researchers, commercial researchers, and academics. These professionals develop advanced and new technologies in order to improve productivity, enhance the data quality of the experiments, decrease the lab process cycle time, and enable experimentation. The most famous application of clinical diagnosis automation and laboratory automation is laboratory robotics. This field comprises many different types of automated instruments and devices such as autosamplers, software algorithms, and various methodologies. These instruments and algorithms are employed to enhance the effectiveness and efficiency of clinical diagnosis in medical laboratories. The application of automation technology in clinical diagnosis is required at present to remain competitive in the market and achieve constant progress. Without automation, laboratories devoted to tasks such as biorepositories, diagnostics, analytical and automated clinical testing, combinatorial chemistry, and high-throughput screening would not have been successfully completed.

Report Overview @ https://www.transparencymarketresearch.com/clinical-diagnosis-automation.html

The most common software and equipment found in the global clinical diagnosis automation market are informatics and software, automated storage, retrieval systems, standalone robots, microplate readers, and automated liquid handling equipment. Diverse clinical diagnosis automation types include modular automation and total lab automation. The testing phases are collected in the segment of total laboratory automation by which all the modules are physically linked by a track system. Total lab automation is appropriate for large size hospitals, however, it leads to a rise in the total cost of automation and thus hence has low market penetration.

The publication is a complete analysis of the growth trajectory in terms of the historical, current, and future prospects of the global clinical diagnosis automation market. It offers an assessment of the elements that are expected to impact the growth of the market and the principal trends have also been mentioned in the study. The report also offers a diverse outlook of the competitive scenario of the market through the value chain and Porter’s five forces analysis. The report mentions the research and development projects, mergers and acquisitions, details on collaborations and licensing.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1105

Global Clinical Diagnosis Automation Market: Trends and Prospects

The primary factors bolstering the growth of the global clinical diagnosis automation market are rising number of suppliers in the global diagnostic market, low rates of reimbursement, and the rising number of diagnosis across the global. As players are striving to gain an established position in the market and have a competitive advantage as well, they are aiming at increasing the productivity and efficiency of the laboratories and curtailing on the total cost. In order to achieve, these, automation has proved to be a potential solution. Currently, the clinical diagnosis sector is on the verge of exploring an innovative automation process. All the phases involved in clinical diagnosis such as sample collection and sample processing are undergoing a huge change and are thus being automated. Clinical analyzers are being used to automate the clinical processes. These analyzers are traceable, fast, and can perform tasks repeatedly. Thus, they can provide patients with reliable and precise results.

Based on product type, the automated analyzers segment led the global clinical diagnosis automation market, whereas the stand-alone automation segment is likely to emerge as the leading segment in terms of growth. Total lab automation is being employed in big hospitals only owing to its inflexibility and problems related to communication.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1105

Global Clinical Diagnosis Automation Market: Regional Outlook

Geographically, the global clinical diagnosis automation market is likely to be dominated by North America owing to the growing diagnosis rate, the introduction of new technologies, and rising geriatric population in the region. Mounting academic and corporate research investments and increasing healthcare awareness is anticipated to bode well for the Asia Pacific market growth.

Companies Mentioned in the Report

The leading companies operating in the market are Siemens Healthcare, Caliper Life Sciences, Bio-Rad Laboratories Inc., Beckman Coulter Inc., and Abbott Diagnostics. The study provides insights into the marketing strategies, products, and shares of the key players operating in the clinical diagnosis automation market.

Popular Research Reports by TMR:

Operating Room Equipment Market: http://www.prnewswire.co.uk/news-releases/operating-room-equipment-market-to-generate-us428733-million-revenue-by-2026-says-tmr-691005331.html

Viral Inactivation Market: https://globenewswire.com/news-release/2018/08/24/1556475/0/en/Viral-Inactivation-Market-is-Projected-to-Surpass-US-5-736-bn-by-2025-Says-TMR.html

Biochemical Reagents Market is Expected To Demonstrate a CAGR of 10.2% from 2017 to 2022

Global Biochemical Reagents Market: Snapshot

The global biochemical reagents market is foretold to gain a good boost in its growth in the next few years on account of detection sensitivity and the advent of new methods, materials, and technology related to clinical biochemistry. The clinical biochemistry technology is reaching a new level, differing from where it was a decade ago, due to the aggressive development of instrument speed and precision.

Today, clinical diagnosis needs could be fulfilled with the use of biochemical analyzer, which is expected to detect a number of projects that cannot be detected with the help of traditional biochemical methods. Considering the development of biochemical tests being highly related to a nation’s healthcare improvement, biochemical detection could be a critical part of clinical testing.

The global biochemical reagents market is foreseen to post a CAGR of 10.2% between 2017 and 2022. By the concluding forecast year, the market could collect a revenue of US$23.1 bn after succeeding from a US$14.2 bn achieved in 2017.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19604

Chromatography Reagents to Lead Way with Staggering Share in View of Revenue

The world biochemical reagents market is prognosticated to be segregated into polymerase chain reaction (PCR) reagent kits, cell and tissue culture reagents, electrophoresis reagents, chromatography reagents, and others as per product classification. According to the report, the market could witness the dominance of chromatography reagents in the coming years. As per the statistics, this segment could gain a total share of 39.6% by 2022 end. During the tenure of the forecast period, the segment is anticipated to expand at an annual growth of approximately US$0.5 bn. This growth could be greater than any other segment in the product category.

As per end user, the world biochemical reagents market is prophesied to be classified into hospitals, diagnostic centers, academics and research, pharma and biotech companies, and contract research organizations (CROs). The analysts provide critical information about the leading segment in this category.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19604

North America to Parade Authority over Market with Colossal Revenue Growth

In terms of geographical segmentation, the international biochemical reagents market is envisaged to be cataloged into Europe, North America, the Middle East and Africa (MEA), Asia Pacific except Japan (APEJ), Japan, and Latin America. Amongst these key regions, North America could exhibit a lion’s share in the market while growing at a CAGR of 10.9%. In 2017, it dominated the market on the basis of revenue. This trend is predicted to continue to take shape in the market throughout the course of the forecast period.

Projected to reach a revenue valuation of US$6.5 bn by the end of 2022, Europe could be next on the list of most lucrative markets for biochemical reagents. Japan is envisioned to expand at a CAGR of 9.7% but may not garner an impressive revenue until the final forecast year. The MEA could be another market with a sluggish growth.

Some of the prominent players operating in the worldwide biochemical reagents market could be Beckton, Dickinson & Company, Merck & Co., Inc., Abbott Laboratories, Agilent Technologies, Inc., and Waters Corporation.